Oz acknowledged obesity isn't "a deficiency of GLP drugs" but called reducing costs "a belt-and-suspenders approach." ...

People taking GLP-1 meds could see costs drop in 2026, thanks to a new federal deal with Eli Lilly and Novo Nordisk, the ...

Find insight on Eli Lilly, Novo Nordisk, AstraZeneca, Hikma Pharmaceuticals in the latest Market Talks covering the Health ...

The deal announced on Thursday, covering Novo's Wegovy and Lilly's Zepbound, will reduce monthly prices for U.S. government ...

The Centers for Medicare & Medicaid Services is launching a new initiative for state Medicaid programs to purchase prescription drugs at prices aligned with those paid in other countries, known as ...

Medicare will start covering obesity drugs for the first time, which could open access to millions of seniors and spur more ...

The White House today announced landmark drug pricing agreements with Eli Lilly and Company and Novo Nordisk to lower the ...

A drug executive collapsed in the Oval Office while President Donald Trump was announcing a deal with drugmakers to reduce ...

A representative from a drug manufacturer fainted during an event at the White House on Thursday, where President Donald ...

A Thursday Oval Office event, where President Donald Trump announced price reductions for weight-loss drugs, was interrupted by a health emergency.

The Trump administration on Thursday rolled out a much-anticipated deal with drugmakers Eli Lilly and Novo Nordisk that aims ...